The key COVID-19 findings in public health, distilled into a clear, readable brief. The evidence is here whenever you want to go deeper.
INSIDE THIS MONITOR
29cited sources
18available findings
Study findings updated
AI-assisted evidence summary. For general information. These findings are not individual medical advice or a clinician endorsement.
THE SHORT VERSION
What’s worth knowing.
The key findings, what they mean, and the context that matters.
THE HEADLINE TAKEAWAY
Estimates for 2025-2026 COVID-19 Vaccines indicated hospitalization protection
An interim test-negative study in adults reported effectiveness of 2025-2026 COVID-19 Vaccines against COVID-19-associated hospitalization, including among adults aged 65+.
Neither the comparator for recipients of 2025-2026 COVID-19 Vaccines nor the follow-up period is available in this summary, so the effectiveness percentages are not featured.
See the evidence
Vaccine effectiveness against COVID-19-associated hospitalization
55% 95% CI: 41%-66%
Wiegand, Ryan E et al.. Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.. JAMA network open. 2026.
Vaccine effectiveness against hospitalization in adults aged 65+
53% 95% CI: 37%-65%
Wiegand, Ryan E et al.. Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.. JAMA network open. 2026.
No clear mortality difference after inter-hospital ICU transfer
No clear difference
Exploratory meta-analyses did not establish a mortality difference between transferred and non-transferred adult COVID-19 ICU patients.
One exploratory analysis pooled 2 studies and another pooled 3; neither adjusted estimate established a difference, and this does not prove equivalence.
See the evidence
The reported result does not establish a difference; it does not prove equivalence.
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=3); the difference was not statistically significant.
OR 1.29 95% CI: 0.84-1.98
Brock, Jonas et al.. Inter-hospital ICU-to-ICU transfer of critically ill COVID-19 patients is not associated with increased mortality: a systematic review with exploratory meta-analysis.. Scientific reports. 2026.
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=2); the difference was not statistically significant.
HR 0.71 95% CI: 0.34-1.46
Brock, Jonas et al.. Inter-hospital ICU-to-ICU transfer of critically ill COVID-19 patients is not associated with increased mortality: a systematic review with exploratory meta-analysis.. Scientific reports. 2026.
Sex/gender differences in mental-health changes were unclear
No clear difference
Pre-pandemic-to-pandemic changes in depression, anxiety and stress did not clearly differ between women or females and men or males.
The cohort meta-analyses retained high risk of bias or other methodological limitations; depression and anxiety analyses also had substantial heterogeneity. No clear difference does not mean equal change.
See the evidence
The reported result does not establish a difference; it does not prove equivalence.
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous depression symptoms; minimal and not statistically significant (12 cohorts; 9,750 participants; I2 = 65.4%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
SMD difference 0.10 95% CI: -0.00 to 0.20; 95% PI: -0.23 to 0.43
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous anxiety symptoms; minimal and not statistically significant (7 cohorts; 6,039 participants; I2 = 68.7%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
SMD difference 0.09 95% CI: -0.04 to 0.22; 95% PI: -0.27 to 0.45
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous stress symptoms; minimal and not statistically significant (8 cohorts; 2,994 participants; I2 = 0%). High risk of bias or other methodological limitations remained present across the analyses.
SMD difference -0.08 95% CI: -0.16 to 0.01; 95% PI: -0.18 to 0.02
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Wellbeing was associated with Long COVID and vaccination
The highest versus lowest CASP-12 psychological wellbeing group had lower odds of long COVID and higher odds of COVID-19 vaccination.
This association was reported in Europeans aged at least 50 years; it does not establish that wellbeing caused either outcome.
Study details & original results
Gao, Yumeng et al.. Association between psychological wellbeing and the COVID-19-related outcomes in Europeans aged ≥ 50 years old: The SHARE study.. Human vaccines & immunotherapeutics. 2026.
Odds of long COVID among participants in the highest versus lowest CASP-12 psychological wellbeing group, corresponding to 23% lower odds
OR 0.77 95% CI: 0.64-0.93
Odds of COVID-19 vaccination among participants in the highest versus lowest CASP-12 psychological wellbeing group
No clear mortality difference after inter-hospital ICU transfer
No clear difference
Exploratory meta-analyses did not establish a mortality difference between transferred and non-transferred adult COVID-19 ICU patients.
One exploratory analysis pooled 2 studies and another pooled 3; neither adjusted estimate established a difference, and this does not prove equivalence.
Study details & original results
Brock, Jonas et al.. Inter-hospital ICU-to-ICU transfer of critically ill COVID-19 patients is not associated with increased mortality: a systematic review with exploratory meta-analysis.. Scientific reports. 2026.
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=3); the difference was not statistically significant.
OR 1.29 95% CI: 0.84-1.98
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=2); the difference was not statistically significant.
HR 0.71 95% CI: 0.34-1.46
The reported result does not establish a difference; it does not prove equivalence.
Sex/gender differences in symptom changes were unclear
No clear difference
Pre-pandemic-to-pandemic changes in depression, anxiety and stress did not clearly differ between women or females and men or males.
High risk of bias or other methodological limitations remained; depression and anxiety analyses also had substantial heterogeneity. These null results do not prove equal changes.
Study details & original results
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous depression symptoms; minimal and not statistically significant (12 cohorts; 9,750 participants; I2 = 65.4%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
SMD difference 0.10 95% CI: -0.00 to 0.20; 95% PI: -0.23 to 0.43
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous anxiety symptoms; minimal and not statistically significant (7 cohorts; 6,039 participants; I2 = 68.7%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
SMD difference 0.09 95% CI: -0.04 to 0.22; 95% PI: -0.27 to 0.45
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous stress symptoms; minimal and not statistically significant (8 cohorts; 2,994 participants; I2 = 0%). High risk of bias or other methodological limitations remained present across the analyses.
SMD difference -0.08 95% CI: -0.16 to 0.01; 95% PI: -0.18 to 0.02
The reported result does not establish a difference; it does not prove equivalence.
Dates show when findings were added here, not when papers were published. Study populations and comparisons differ.
WHEN YOU WANT TO GO DEEPERSee all 18 findingsOriginal results, comparisons and study details.
9 of 9 source groupsFindings stay together with their study.
SOURCE 292 findings
Gao, Yumeng et al.. Association between psychological wellbeing and the COVID-19-related outcomes in Europeans aged ≥ 50 years old: The SHARE study.. Human vaccines & immunotherapeutics. 2026.
Brock, Jonas et al.. Inter-hospital ICU-to-ICU transfer of critically ill COVID-19 patients is not associated with increased mortality: a systematic review with exploratory meta-analysis.. Scientific reports. 2026.
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=3); the difference was not statistically significant.
Adjusted mortality among transferred versus non-transferred adult COVID-19 ICU patients in an exploratory meta-analysis (k=2); the difference was not statistically significant.
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous anxiety symptoms; minimal and not statistically significant (7 cohorts; 6,039 participants; I2 = 68.7%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
Added
SMD difference 0.0995% CI: -0.04 to 0.22; 95% PI: -0.27 to 0.45Source [27]
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous depression symptoms; minimal and not statistically significant (12 cohorts; 9,750 participants; I2 = 65.4%). Substantial heterogeneity, high risk of bias, or both were present across analyses.
Added
SMD difference 0.1095% CI: -0.00 to 0.20; 95% PI: -0.23 to 0.43Source [27]
All 3 findings from this source
Difference between women or females and men or males in prepandemic-to-pandemic change in continuous stress symptoms; minimal and not statistically significant (8 cohorts; 2,994 participants; I2 = 0%). High risk of bias or other methodological limitations remained present across the analyses.
Added
SMD difference -0.0895% CI: -0.16 to 0.01; 95% PI: -0.18 to 0.02Source [27]
SOURCE 011 finding
Wang H, Paulson KR, Pease SA, et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513-1536.
2.3xHispanic vs White mortality ratio (age-adjusted)Source [2]
SOURCE 031 finding
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023;21(3):133-146.
90-95%mRNA VE against symptomatic infection (95% CI: 88-97%)Source [4]
SOURCE 253 findings
Li, Shen et al.. Global prevalence of prolonged grief disorder during the COVID-19 pandemic under standardized diagnostic frameworks: A systematic review and meta-analysis.. Psychological medicine. 2026.
Wiegand, Ryan E et al.. Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.. JAMA network open. 2026.
Browse the 29 original sourcesThe complete bibliography behind this monitor.
[1]
Wang H, Paulson KR, Pease SA, et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513-1536.
APM Research Lab. The color of coronavirus: COVID-19 deaths by race and ethnicity in the U.S. Updated 2021.
Original source link unavailable
[3]
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023;21(3):133-146.
Watson OJ, Barnsley G, Toor J, et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infectious Diseases. 2022;22(9):1293-1302.
Bobrovitz N, Ware H, Ma X, et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease. Lancet Infectious Diseases. 2023;23(5):556-567.
Feikin DR, Higdon MM, Abu-Raddad LJ, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression. Lancet. 2022;399(10328):924-944.
PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK. Lancet Respiratory Medicine. 2022;10(8):761-775.
Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-COVID-19 condition or long COVID: A meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593-1607.
Arrazola J, Masiello MM, Joshi S, et al. COVID-19 mortality among American Indian and Alaska Native persons - 14 States, January-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(49):1853-1856.
COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700-1712.
Shanafelt TD, West CP, Dyrbye LN, et al. Changes in burnout and satisfaction with work-life integration in physicians and the general US working population between 2011 and 2020. Mayo Clin Proc. 2022;97(3):491-506.
Notarte KI, Catahay JA, Velasco JV, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624.
Thompson MG, Stenehjem E, Grannis S, et al. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings. N Engl J Med. 2021;385(15):1355-1371.
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-2059.
Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-1581.
Li, Shen et al.. Global prevalence of prolonged grief disorder during the COVID-19 pandemic under standardized diagnostic frameworks: A systematic review and meta-analysis.. Psychological medicine. 2026.
Wiegand, Ryan E et al.. Interim Estimated Effectiveness of 2025-2026 COVID-19 Vaccines in Adults Using a Test-Negative Design.. JAMA network open. 2026.
Sung, Gabriel Chun Yin et al.. Mental Health Symptom Changes by Sex or Gender Before and During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.. JAMA network open. 2026.
Brock, Jonas et al.. Inter-hospital ICU-to-ICU transfer of critically ill COVID-19 patients is not associated with increased mortality: a systematic review with exploratory meta-analysis.. Scientific reports. 2026.
Gao, Yumeng et al.. Association between psychological wellbeing and the COVID-19-related outcomes in Europeans aged ≥ 50 years old: The SHARE study.. Human vaccines & immunotherapeutics. 2026.
This is an AI-assisted evidence summary, not a clinician endorsement. Read each original paper for its complete methods, population and limitations. Different studies can ask different questions and report different kinds of results.
Dates marked “added” describe when a finding entered this monitor, not when the study was published or clinically reviewed. Personal health and treatment decisions belong in a conversation with a qualified clinician.